Tetra Bio Pharma Inc (TBP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 05-2021 | 02-2021 | 11-2020 | 08-2020 | 05-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 33 | 16 | 10 | -19 | 37 |
| Accounts receivable | -45 | 162 | -297 | -19 | -38 |
| Other Working Capital | -4,572 | 4,518 | 1,075 | 635 | -648 |
| Other Operating Activity | -6,286 | -8,549 | -9,203 | -3,609 | -4,504 |
| Operating Cash Flow | $-10,869 | $-3,853 | $-8,415 | $-3,012 | $-5,154 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -49 | -178 | -51 | -125 | -47 |
| Net Acquisitions | 0 | -313 | -1,265 | 0 | N/A |
| Purchase Of Investment | N/A | N/A | N/A | -640 | N/A |
| Purchase Sale Intangibles | -742 | -15 | -1,516 | 0 | 0 |
| Other Investing Activity | 0 | -506 | 952 | 0 | -313 |
| Investing Cash Flow | $-791 | $-1,012 | $-1,880 | $-765 | $-360 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,250 | 1,750 | N/A | N/A | N/A |
| Debt Repayment | -1,217 | -783 | N/A | N/A | N/A |
| Common Stock Issued | 22,537 | 1,884 | 0 | 0 | 9,150 |
| Other Financing Activity | 4,297 | 36 | 0 | 0 | 913 |
| Financing Cash Flow | $26,867 | $2,888 | $0 | $0 | $10,063 |
| Beginning Cash Position | 1,028 | 2,501 | 11,058 | 16,518 | 11,972 |
| End Cash Position | 16,236 | 1,028 | 2,501 | 11,058 | 16,518 |
| Net Cash Flow | $15,207 | $-1,472 | $-10,295 | $-3,778 | $4,550 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,869 | -3,853 | -8,415 | -3,012 | -5,154 |
| Capital Expenditure | -791 | -194 | -1,567 | -125 | -47 |
| Free Cash Flow | -11,660 | -4,047 | -9,982 | -3,138 | -5,201 |